Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China

10.3389/fphar.2021.717504

Saved in:

Bibliographic Details
Main Authors:	Liu, Jinyu, Zhang, Yu, Wu, Bin, Wang, Sen, Bin-Chia Wu, David, You, Ruxu
Other Authors:	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
Format:	Article
Published:	Frontiers Media S.A. 2022
Subjects:	baseline testing cost-effectiveness elbasvir/grazoprevir hepatitis C virus resistance-associated polymorphisms
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/233631
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-233631
record_format	dspace
spelling	sg-nus-scholar.10635-2336312023-09-01T09:15:13Z Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China Liu, Jinyu Zhang, Yu Wu, Bin Wang, Sen Bin-Chia Wu, David You, Ruxu SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH baseline testing cost-effectiveness elbasvir/grazoprevir hepatitis C virus resistance-associated polymorphisms 10.3389/fphar.2021.717504 Frontiers in Pharmacology 12 717504 2022-10-26T09:07:16Z 2022-10-26T09:07:16Z 2021-10-15 Article Liu, Jinyu, Zhang, Yu, Wu, Bin, Wang, Sen, Bin-Chia Wu, David, You, Ruxu (2021-10-15). Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China. Frontiers in Pharmacology 12 : 717504. ScholarBank@NUS Repository. https://doi.org/10.3389/fphar.2021.717504 1663-9812 https://scholarbank.nus.edu.sg/handle/10635/233631 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ Frontiers Media S.A. Scopus OA2021
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	baseline testing cost-effectiveness elbasvir/grazoprevir hepatitis C virus resistance-associated polymorphisms
spellingShingle	baseline testing cost-effectiveness elbasvir/grazoprevir hepatitis C virus resistance-associated polymorphisms Liu, Jinyu Zhang, Yu Wu, Bin Wang, Sen Bin-Chia Wu, David You, Ruxu Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China
description	10.3389/fphar.2021.717504
author2	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
author_facet	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Liu, Jinyu Zhang, Yu Wu, Bin Wang, Sen Bin-Chia Wu, David You, Ruxu
format	Article
author	Liu, Jinyu Zhang, Yu Wu, Bin Wang, Sen Bin-Chia Wu, David You, Ruxu
author_sort	Liu, Jinyu
title	Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China
title_short	Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China
title_full	Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China
title_fullStr	Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China
title_full_unstemmed	Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China
title_sort	cost-effectiveness of testing for ns5a resistance to optimize treatment of elbasvir/grazoprevir for chronic hepatitis c in china
publisher	Frontiers Media S.A.
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/233631
_version_	1779155323032961024

Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China

Similar Items